Turning Point Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2013-10-08
- Employees
- 251
- Market Cap
- -
Zai Lab announces the inclusion of Augtyro for ROS1+ NSCLC and other updates in China's
Zai Lab announces NRDL inclusion of Augtyro for ROS1+ NSCLC, renewal of Nuzyra for CABP/ABSSSI, and Qinlock for GIST, expanding patient access to innovative treatments in China.
© Copyright 2024. All Rights Reserved by MedPath